Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-056807

SVP, COO & CFO sold 25,000 shares at $19.79 ($494,750)

  • SVP, COO & CFO acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Labrucherie Gil M · SVP, COO & CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-11-13 Exercise or conversion : show line 1 in the form +25,000 $7.21 $180,250 252,872 D
2019-11-13 Sale : show line 2 in the form −25,000 $19.79 $494,750 227,872 D
Open-market sales · 25,000 sh · avg $19.79 · $494,750

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-11-13 Exercise or conversion : show line 3 in the form Stock Option −25,000 0 D
Loading xslF345X03/doc4.xml…